NCT03625102 - A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

June 16, 2023

Study Completion Date

June 16, 2023

Conditions

HBV

Interventions

DRUG

Antroquinonol

Antroquinonol will be provided as a capsule-shaped which contain 50 mg Antroquinonol.

OTHER

placebo

The matching placebo will be packaged as Antroquinonol with appearance identical in all aspects

Trial Locations (1)

Chung Shan Medical University Hospital, Taichung